2001
DOI: 10.1097/00007890-200111150-00013
|View full text |Cite
|
Sign up to set email alerts
|

Cd103+ CTL Accumulate Within the Graft Epithelium During Clinical Renal Allograft Rejection1

Abstract: These data implicate CD103 as a homing receptor that targets graft-infiltrating CD8+ CTLs to the graft epithelium. Given the strong association of tubulitis with clinical rejection, these data are consistent with a role for the CD103+ CTL subset as an effector mechanism in renal allograft destruction.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
31
0

Year Published

2004
2004
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(35 citation statements)
references
References 24 publications
4
31
0
Order By: Relevance
“…As shown in Fig. 3A, left panel, CD103 expression by GIL was strongly biased toward the CD8 subset, a distribution highly similar to that previously described for rejecting clinical renal allografts (27). Thus, this model recapitulates the known clinical scenario in which subclinical tubulointerstitial inflammation in renal allografts is accompanied by accumulation of CD103 ϩ CD8 ϩ cells at the graft site concomitant with development of tubular atrophy and interstitial fibrosis.…”
Section: Progressive Accumulation Of Cd103supporting
confidence: 80%
See 2 more Smart Citations
“…As shown in Fig. 3A, left panel, CD103 expression by GIL was strongly biased toward the CD8 subset, a distribution highly similar to that previously described for rejecting clinical renal allografts (27). Thus, this model recapitulates the known clinical scenario in which subclinical tubulointerstitial inflammation in renal allografts is accompanied by accumulation of CD103 ϩ CD8 ϩ cells at the graft site concomitant with development of tubular atrophy and interstitial fibrosis.…”
Section: Progressive Accumulation Of Cd103supporting
confidence: 80%
“…Importantly, the intragraft localization and extended phenotype of CD103 ϩ CD8 ϩ cells (Fig. 3) that accumulate in rat renal allografts in our model are virtually identical to those associated with rejecting clinical renal allografts (13,27). The clinical relevance of the CsA-delayed rejection model is further supported by the observation that CD103 ϩ CD8 ϩ effectors are undetectable in clinical renal allografts undergoing early rejection episodes (33) but are abundant in grafts undergoing delayed rejection episodes (13,27).…”
Section: Discussionsupporting
confidence: 55%
See 1 more Smart Citation
“…In vitro, CD103 + CD8 + T cells even surpass CD103 -cells in cytotoxic killing capacity. CD103 + T cells have been shown before to be very potent cytotoxic killers in a number of other settings (41)(42)(43)(44)(45)(46). Additionally, CD103 + CD8 + lung T cells are also strong Th1 cytokine producers.…”
Section: Discussionmentioning
confidence: 99%
“…Production of active TGF-␤ by renal tubular epithelial cells is markedly increased in the rejecting kidney, inducing CD103 expression on activated graft-infiltrating T cells (32). Indeed, this TGF-␤-mediated process appears to be required for development of tubulitis and CTL lysis of renal tubular epithelial cells (33). The benign interstitial infiltrates in renal transplants of graft recipients without maintenance immunosuppression (34) are therefore puzzling, because they may also be associated with elevated intragraft expression of TGF-␤1 (35,36).…”
Section: Discussionmentioning
confidence: 99%